Breadcrumb Trail Links
Business Wire News ReleasesPMN Press Releases
Article content
CAMBRIDGE, Ontario — ATS Corporation (TSX and NYSE: ATS) (“ATS” or the “Company”) today reported its financial results for the three and nine months ended December 29, 2024. All references to “$” or “dollars” in this news release are to Canadian dollars unless otherwise indicated.
Article content
Article content
Third quarter highlights:
Revenues were $652.0 million compared to $752.0 million a year ago.Net income was $6.5 million compared to $47.2 million a year ago.Basic earnings per share were 7 cents, compared to 48 cents a year ago.Adjusted EBITDA1 was $87.5 million compared to $119.3 million a year ago.Adjusted basic earnings per share1 were 32 cents compared to 65 cents a year ago.Order Bookings2 were $883 million, 32.2% higher compared to $668 million a year ago.Order Backlog2 was $2,060 million, 8.0% higher compared to $1,907 million a year ago.
Advertisement 2
Article content
“Today ATS reported third quarter results for fiscal ’25. Order Bookings this quarter reflected strong organic growth and contributions from our acquisitions,” said Andrew Hider, Chief Executive Officer. “As anticipated, third quarter results were impacted by lower revenues as a result of reduced market demand in the North American EV market, partially offset by strong and diversified growth in life sciences and food and beverage.”
Year-to-date highlights:
Revenues were $1,959.0 million compared to $2,241.4 million a year ago.Net Income was $40.9 million compared to $145.7 million a year ago.Basic earnings per share were 42 cents, compared to $1.49 a year ago.Adjusted EBITDA1 was $271.8 million compared to $354.6 million a year ago.Adjusted basic earnings per share1 were $1.07 compared to $1.96 a year ago.Order Bookings1 were $2,442 million, compared to $2,100 million a year ago.
Mr. Hider added: “Q3 was the second highest bookings quarter in company history. As we transition into the final quarter of the fiscal year and look ahead to fiscal 2026, our significant Order Backlog provides good revenue visibility and a solid foundation for ATS to drive customer and shareholder value creation.”
1 Non-IFRS measure: see “Non-IFRS and Other Financial Measures”.
2 Supplementary financial measure: see “Non-IFRS and Other Financial Measures”.
Financial results
(In millions of dollars, except per share and margin data)
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Variance
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Variance
Revenues
$
652.0
$
752.0
(13.3)%
$
1,959.0
$
2,241.4
(12.6)%
Net income
$
6.5
$
47.2
(86.2)%
$
40.9
$
145.7
(71.9)%
Adjusted earnings from operations1
$
65.7
$
101.2
(35.1)%
$
208.3
$
301.6
(30.9)%
Adjusted earnings from operations margin2
10.1%
13.5%
(338)bps
10.6%
13.5%
(282)bps
Adjusted EBITDA1
$
87.5
$
119.3
(26.7)%
$
271.8
$
354.6
(23.4)%
Adjusted EBITDA margin2
13.4%
15.9%
(244)bps
13.9%
15.8%
(195)bps
Basic earnings per share
$
0.07
$
0.48
(85.4)%
$
0.42
$
1.49
(71.8)%
Adjusted basic earnings per share1
$
0.32
$
0.65
(50.8)%
$
1.07
$
1.96
(45.4)%
Order Bookings3
$
883
$
668
32.2%
$
2,442
$
2,100
16.3%
As At
December 29
2024
December 31
2023
Variance
Order Backlog3
$
2,060
$
1,907
8.0%
1 Non-IFRS financial measure – See “Non-IFRS and Other Financial Measures”.
2 Non-IFRS ratio – See “Non-IFRS and Other Financial Measures”.
3 Supplementary financial measure – See “Non-IFRS and Other Financial Measures”.
Advertisement 3
Article content
Recent Acquisitions
On July 24, 2024, the Company acquired Paxiom Group (“Paxiom”). With headquarters in Montreal, Canada, Paxiom is a provider of primary, secondary, and end-of-line packaging machines in the food & beverage, cannabis, and pharmaceutical industries. Paxiom’s product line is expected to complement ATS’ packaging and food technology businesses and allow ATS to offer complete packaging and end-of-line solutions. The total purchase price paid (based on finalization of post-closing adjustments) was $146.4 million.
On August 30, 2024, the Company acquired all material assets of Heidolph Instruments GmbH & Co. KG and Hans Heidolph GmbH (“Hiedolph”), a leading manufacturer of premium lab equipment for the life sciences and pharmaceutical industries, with headquarters in Schwabach, Germany and facilities in the United States (“U.S.”), South Korea and China. The purchase price paid in the second quarter of fiscal 2025 was $45.1 million ($30.3 million Euros).
Third quarter summary
Third quarter of fiscal 2025 revenues were 13.3% or $100.0 million lower than in the corresponding period a year ago, primarily reflecting a year-over-year decrease in organic revenue (excluding contributions from acquired companies and foreign exchange translation) of $151.8 million or 20.2%, partially offset by revenues earned by acquired companies of $41.5 million, which included $18.7 million from Heidolph and $13.2 million from Paxiom. Revenues generated from construction contracts decreased 29.2% or $141.6 million from the prior period due to lower Order Backlog entering the period, primarily within the transportation market which included several large electric vehicle (“EV”) Order Bookings a year ago. Revenues from services increased 3.3% or $5.0 million, primarily due to revenues earned by acquired companies of $4.8 million. Revenues from the sale of goods increased 32.2% or $36.6 million primarily due to revenues earned by acquired companies of $26.2 million, most notably from Avidity Science, LLC (“Avidity”), in addition to organic revenue growth on higher Order Backlog entering the period.
By market, revenues generated in life sciences increased $59.3 million or 18.7% year over year. This was primarily due to contributions from acquisitions totalling $28.3 million, notably from Avidity, and organic revenue growth on higher Order Backlog entering the quarter. Revenues generated in food & beverage increased $18.4 million or 19.4% from the corresponding period last year due to contributions from acquisitions of $13.2 million and organic revenue growth on higher Order Backlog entering the quarter. Revenues in transportation decreased $190.6 million or 79.3% year over year, due to lower Order Backlog entering the quarter, as the prior year included several large EV projects. Revenues generated in consumer products increased $16.2 million or 23.5% year over year due to higher Order Backlog entering the quarter, and execution on increased in-quarter Order Bookings compared to the previous quarter. Revenues in energy decreased $3.3 million or 10.7% due to timing of program execution.
Article content
Advertisement 4
Article content
Net income for the third quarter of fiscal 2025 was $6.5 million (7 cents per share basic), compared to net income of $47.2 million (48 cents per share basic) for the third quarter of fiscal 2024. The decrease primarily reflected lower revenues, and higher selling, general, and administrative (“SG&A”), partially offset by increased gross margin profitability and lower restructuring costs. Adjusted basic earnings per share were 32 cents compared to 65 cents in the third quarter of fiscal 2024 (adjusted basic earnings per share is a non-IFRS financial measure — see “Non-IFRS and Other Financial Measures” and “Reconciliation of Non-IFRS Measures to IFRS Measures”).
Depreciation and amortization expense was $37.9 million in the third quarter of fiscal 2025, compared to $35.2 million a year ago.
Order Backlog Continuity
(In millions of dollars)
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Opening Order Backlog
$
1,824
$
2,016
$
1,793
$
2,153
Revenues
(652)
(752)
(1,959)
(2,241)
Order Bookings
883
668
2,442
2,100
Order Backlog adjustments1
5
(25)
(216)
2
(105)
Total
$
2,060
$
1,907
$
2,060
$
1,907
1 Order Backlog adjustments include incremental Order Backlog of acquired companies ($12 million acquired with Paxiom in the nine months ended December 29, 2024, and $4 million acquired with Avidity in the three and nine months ended December 31, 2023), foreign exchange adjustments, scope changes and cancellations.2 See Management’s Discussion and Analysis for the three and six months ended September 29, 2024 (“Q2F25 MD&A”).
Advertisement 5
Article content
Order Bookings
Third quarter of fiscal 2025 Order Bookings were $883 million, a 32.2% year-over-year increase, reflecting an increase of 21.9% in organic Order Bookings growth, in addition to 8.2% of growth from acquired companies and 2.1% from positive foreign exchange translation impacts. Order Bookings from acquired companies totalled $54.5 million. By market, Order Bookings in life sciences increased compared to the prior-year period primarily due to organic growth, along with $35.8 million of contributions from acquired companies, including $23.2 million from Heidolph. Order Bookings in food & beverage increased from the prior period due to contributions from acquired companies of $18.8 million. Order Bookings in transportation increased compared to the prior-year period due to timing of customer projects. Order Bookings in consumer products increased from the prior period primarily due to the timing of customer projects. Order Bookings in energy increased compared to the prior-year period primarily due to timing of customer projects.
Trailing twelve month book-to-bill ratio at December 29, 2024 was 1.18:1. Book-to-bill ratio, Order Bookings and organic Order Bookings growth are supplementary financial measures — see “Non-IFRS and Other Financial Measures.”
Backlog
At December 29, 2024, Order Backlog was $2,060 million, 8.0% higher than at December 31, 2023, primarily on account of higher Order Backlog in life sciences, consumer products, food & beverage and energy markets, partially offset by lower Order Backlog within the transportation market which included several large EV Order Bookings a year ago.
Outlook
The life sciences funnel remains strong, with a focus on strategic submarkets of pharmaceuticals, radiopharmaceuticals, and medical devices. Management continues to identify opportunities with both new and existing customers, including those who produce auto-injectors and wearable devices for diabetes and obesity treatments, contact lenses and pre-filled syringes, automated pharmacy solutions, as well as opportunities to provide life science solutions that leverage integrated capabilities from across ATS. Funnel activity in food & beverage remains strong. The Company continues to benefit from strong brand recognition within the global tomato processing, other soft fruits processing and vegetable processing industries, and there is continued interest in automated solutions within the food & beverage market more broadly. In transportation, the funnel consists of smaller opportunities relative to the size of the Order Bookings received throughout fiscal years 2023 and 2024 as North American industry participants continue to moderate new capacity investment to match end market demand and reduce platform costs. See “Update on Large EV Customer” below. Funnel activity in consumer products is stable, although discretionary spending by consumers, influenced by factors such as inflationary pressures, may impact timing of some customer investments in the Company’s solutions. Funnel activity in energy remains strong and includes longer-term opportunities in the nuclear industry. The Company is focused on clean energy applications including solutions for the refurbishment of nuclear power plants, early participation in the small modular reactor market, and grid battery storage.
Advertisement 6
Article content
Funnel growth in markets where environmental, social and governance requirements are an increasing focus for customers — including nuclear and grid battery storage, as well as consumer goods packaging — provide ATS with opportunities to use its capabilities to respond to customer sustainability standards and goals, including global and regional requirements to reduce carbon emissions. Customers seeking to de-risk or enhance the resiliency of their supply chains, address a shortage of skilled workers or combat higher labour costs also provide future opportunities for ATS to pursue. Management believes that the underlying trends driving customer demand for ATS solutions including rising labour costs, labour shortages, production onshoring or reshoring and the need for scalable, high-quality, energy-efficient production remain favourable.
Order Backlog of $2,060 million is expected to help mitigate some of the impact of quarterly variability in Order Bookings on revenues in the short term. The Company’s Order Backlog includes several large enterprise programs that have longer periods of performance and therefore longer revenue recognition cycles, particularly in life sciences. In the fourth quarter of fiscal 2025, management expects to generate revenues in the range of $650 million to $710 million. This estimate is calculated each quarter based on management’s assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity. In the short-term, management expects lower transportation revenues to continue to negatively impact margins, until reorganization actions are fully implemented.
Supplier lead times are generally acceptable across key categories; however, inflationary or other cost increases, price and lead-time volatility have and may continue to disrupt the timing and progress of the Company’s margin expansion efforts and affect revenue recognition. Over time, achieving management’s margin target assumes that the Company will successfully implement its margin expansion initiatives, and that such initiatives will result in improvements to its adjusted earnings from operations margin that offset these shorter-term pressures (see “Forward-Looking Statements” for a description of the risks underlying the achievement of the margin target in future periods).
Advertisement 7
Article content
The timing of customer decisions on larger opportunities is expected to cause variability in Order Bookings from quarter to quarter, and may be influenced as a result of tariffs. Revenues in a given period are dependent on a combination of the volume of outstanding projects the Company is contracted to perform, the size and duration of those projects, and the timing of project activities including design, assembly, testing, and installation. Given the specialized nature of the Company’s offerings, the size and scope of projects vary based on customer needs. The Company seeks to achieve revenue growth organically and by identifying strategic acquisition opportunities that provide access to attractive end-markets and new products and technologies and deliver hurdle-rate returns. After-sales revenues and reoccurring revenues, which ATS defines as revenues from ancillary products and services associated with equipment sales, and revenues from customers who purchase non-customized ATS product at regular intervals, are expected to provide some balance to customers’ capital expenditure cycles.
The Company continues to make progress in line with its plans to integrate acquired companies, and expects to realize cost and revenue synergies consistent with announced integration plans.
Advertisement 8
Article content
Reorganization Activities
In the third quarter of fiscal 2025, restructuring expenses of $3.3 million were recorded in relation to the Company’s previously disclosed reorganization activities. For the nine months ended December 29, 2024, total costs of $20.4 million were recorded.
Update on Large EV Customer
As disclosed in the Company’s Q2F25 MD&A, management has been, and continues to be, engaged in discussions with a particular customer of certain large EV programs with respect to outstanding payments owed and completing the commissioning of these projects in order to receive final milestone payments. While work remains paused on these projects, management has been and continues to be focused on efforts to resolve disagreements with the customer. The Company is prepared to consider all legal avenues available to it, including dispute resolution mechanisms and litigation, if necessary (see “Risk Factors”).
The Company has outstanding and overdue accounts receivable of approximately $165 million from this customer and approximately $175 million of contract assets reflecting work completed and remaining to be invoiced. Foreign currency revaluation drove the change in these amounts compared to the values disclosed in the Company’s Q2F25 MD&A. The Company believes that it has fulfilled its obligations under the contracts with this customer and that it is owed these amounts for work completed.
Tariffs
Risk Factors
Risks applicable to ATS’ business operations are described in the Company’s AIF under “Risk Factors.” The AIF is available on SEDAR+ at www.sedarplus.com and on the U.S. Securities Exchange Commission’s EDGAR at www.sec.gov. Such risks described in the AIF remain substantially unchanged. In addition, with respect to the information provided in “Update on Large EV Customer” herein, the risks titled “Litigation risk” and “Customer concentration risk” in the AIF specifically apply and are supplemented by an additional “Customer disagreement risk” in the Company’s management’s discussion and analysis for the third quarter of fiscal 2025 (the “Q3F25 MD&A”) (see “Risk Factors” in the Q3F25 MD&A). In addition, the risk titled “International trade risk” in the AIF is supplemented as described in the Q3F25 MD&A.
Advertisement 9
Article content
Quarterly Conference Call
ATS will host a conference call and webcast at 8:30 a.m. eastern on Wednesday, February 5, 2025 to discuss its quarterly results. The listen-only webcast can be accessed live at www.atsautomation.com. The conference call can be accessed live by dialing (888) 660-6652 or (646) 960-0554 five minutes prior. A replay of the conference will be available on the ATS website following the call. Alternatively, a telephone recording of the call will be available for one week (until midnight February 12, 2025) by dialing (800) 770-2030 and using the access code 8782510.
About ATS
ATS Corporation is an industry-leading automation solutions provider to many of the world’s most successful companies. ATS uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added solutions including pre-automation and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, transportation, food & beverage, consumer products, and energy. Founded in 1978, ATS employs over 7,500 people at more than 65 manufacturing facilities and over 85 offices in North America, Europe, Asia and Oceania. The Company’s common shares are traded on the Toronto Stock Exchange (“TSX”) and the New York Stock Exchange (“NYSE”) under the symbol ATS. Visit the Company’s website at www.atsautomation.com.
Consolidated Revenues
(In millions of dollars)
Revenues by type
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Revenues from construction contracts
$
343.6
$
485.2
$
1,056.0
$
1,473.8
Services rendered
158.0
153.0
491.8
444.4
Sale of goods
150.4
113.8
411.2
323.2
Total revenues
$
652.0
$
752.0
$
1,959.0
$
2,241.4
Revenues by market
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Life Sciences
$
376.1
$
316.8
$
1,054.9
$
893.3
Food & Beverage
113.3
94.9
304.0
335.3
Transportation
49.8
240.4
263.4
711.2
Consumer Products
85.2
69.0
246.4
217.2
Energy
27.6
30.9
90.3
84.4
Total revenues
$
652.0
$
752.0
$
1,959.0
$
2,241.4
Consolidated Operating Results
(In millions of dollars)
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Earnings from operations
$
33.1
$
78.5
$
122.8
$
240.6
16.1
17.1
51.2
51.8
1.0
0.9
3.2
2.1
2.1
0.8
3.8
0.8
Gain on sale of facilities
—
(11.7
)
—
(11.7
)
Restructuring charges
3.3
16.2
20.4
16.2
Settlement costs
8.7
—
8.7
—
Mark to market portion of stock-based compensation
1.4
(0.6
)
(1.8
)
1.8
Adjusted earnings from operations1
$
65.7
$
101.2
$
208.3
$
301.6
1 Non-IFRS Financial Measure, See “Non-IFRS and Other Financial Measures”
Advertisement 10
Article content
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Earnings from operations
$
33.1
$
78.5
$
122.8
$
240.6
Depreciation and amortization
37.9
35.2
114.7
104.8
EBITDA1
$
71.0
$
113.7
$
237.5
$
345.4
Restructuring charges
3.3
16.2
20.4
16.2
1.0
0.9
3.2
2.1
2.1
0.8
3.8
0.8
Settlement costs
8.7
—
8.7
—
Mark to market portion of stock-based compensation
1.4
(0.6
)
(1.8
)
1.8
Gain on sale of facilities
—
(11.7
)
—
(11.7
)
Adjusted EBITDA1
$
87.5
$
119.3
$
271.8
$
354.6
1 Non-IFRS Financial Measure, See “Non-IFRS and Other Financial Measures”
Order Backlog by Market
(In millions of dollars)
As at
December 29
2024
December 31
2023
Life Sciences
$
1,220
$
875
Food & Beverage
252
207
Transportation
250
564
Consumer Products
180
161
Energy
158
100
Total
$
2,060
$
1,907
Reconciliation of Non-IFRS Measures to IFRS Measures
(In millions of dollars, except per share data)
The following table reconciles adjusted EBITDA and EBITDA to the most directly comparable IFRS measure (net income):
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Adjusted EBITDA
$
87.5
$
119.3
$
271.8
$
354.6
Less: restructuring charges
3.3
16.2
20.4
16.2
1.0
0.9
3.2
2.1
2.1
0.8
3.8
0.8
Settlement costs
8.7
—
8.7
—
Less: mark to market portion of stock-based compensation
1.4
(0.6
)
(1.8
)
1.8
Less: gain on sale of facilities
—
(11.7
)
—
(11.7
)
EBITDA
$
71.0
$
113.7
$
237.5
$
345.4
Less: depreciation and amortization expense
37.9
35.2
114.7
104.8
Earnings from operations
$
33.1
$
78.5
$
122.8
$
240.6
Less: net finance costs
22.5
17.5
65.5
49.9
Less: provision for income taxes
4.1
13.8
16.4
45.0
Net income
$
6.5
$
47.2
$
40.9
$
145.7
The following table reconciles adjusted earnings from operations, adjusted net income, and adjusted basic earnings per share to the most directly comparable IFRS measures (net income (loss) and basic earnings (loss) per share):
Three Months Ended December 29, 2024
Three Months Ended December 31, 2023
Earnings
from
operations
Finance
costs
Provision
for income
taxes
Net
income
Basic
EPS
Earnings
from
operations
Finance
costs
Provision
for income
taxes
Net
income
Basic
EPS
Reported (IFRS)
$
33.1
$
(22.5
)
$
(4.1
)
$
6.5
$
0.07
$
78.5
$
(17.5
)
$
(13.8
)
$
47.2
$
0.48
16.1
—
—
16.1
0.17
17.1
—
—
17.1
0.17
Restructuring charges
3.3
—
—
3.3
0.03
16.2
—
—
16.2
0.16
2.1
—
—
2.1
0.02
0.8
—
—
0.8
0.01
1.0
—
—
1.0
0.01
0.9
—
—
0.9
0.01
Settlement costs
8.7
—
—
8.7
0.09
—
—
—
—
—
Mark to market portion of stock-based compensation
1.4
—
—
1.4
0.01
(0.6
)
—
—
(0.6
)
(0.01
)
Gain on sale of facilities
—
—
—
—
—
(11.7
)
—
—
(11.7
)
(0.11
)
Tax effect of the above adjustments1
—
—
(8.2
)
(8.2
)
(0.08
)
—
—
(6.0
)
(6.0
)
(0.06
)
Adjusted (non-IFRS)
$
65.7
$
30.9
$
0.32
$
101.2
$
63.9
$
0.65
1 Adjustments to provision for income taxes relate to the income tax effects of adjustment items that are excluded for the purposes of calculating non-IFRS based adjusted net income.
Advertisement 11
Article content
Nine Months Ended December 29, 2024
Nine Months Ended December 31, 2023
Earnings
from
operations
Finance
costs
Provision
for income
taxes
Net
income
Basic
EPS
Earnings
from
operations
Finance
costs
Provision
for income
taxes
Net
income
Basic
EPS
Reported (IFRS)
$
122.8
$
(65.5
)
$
(16.4
)
$
40.9
$
0.42
$
240.6
$
(49.9
)
$
(45.0
)
$
145.7
$
1.49
51.2
—
—
51.2
0.52
51.8
—
—
51.8
0.53
Restructuring charges
20.4
—
—
20.4
0.21
16.2
—
—
16.2
0.17
3.8
—
—
3.8
0.04
0.8
—
—
0.8
0.01
3.2
—
—
3.2
0.03
2.1
—
—
2.1
0.02
Settlement costs
8.7
—
—
8.7
0.09
—
—
—
—
—
Mark to market portion of stock-based compensation
(1.8
)
—
—
(1.8
)
(0.02
)
1.8
—
—
1.8
0.02
Gain on sale of facilities
—
—
—
—
—
(11.7
)
—
—
(11.7
)
(0.12
)
Tax effect of the above adjustments1
—
—
(22.0
)
(22.0
)
(0.22
)
—
—
(15.6
)
(15.6
)
(0.16
)
Adjusted (non-IFRS)
$
208.3
$
104.4
$
1.07
$
301.6
$
191.1
$
1.96
1 Adjustments to provision for income taxes relate to the income tax effects of adjustment items that are excluded for the purposes of calculating non-IFRS based adjusted net income.
The following table reconciles organic revenue to the most directly comparable IFRS measure (revenue):
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Organic revenue
$
600.2
$
706.2
$
1,820.8
$
2,096.5
Revenues of acquired companies
41.5
29.7
112.3
59.5
Impact of foreign exchange rate changes
10.3
16.1
25.9
85.4
Total revenue
$
652.0
$
752.0
$
1,959.0
$
2,241.4
Organic revenue growth
(20.2
)%
(18.8
)%
The following table reconciles non-cash working capital as a percentage of revenues to the most directly comparable IFRS measures:
As at
December 29
2024
March 31
2024
Accounts receivable
$
709.1
$
471.3
Income tax receivable
17.7
13.4
Contract assets
619.5
704.7
Inventories
366.2
295.9
Deposits, prepaids and other assets
98.9
98.2
Accounts payable and accrued liabilities
(629.8
)
(604.5
)
Income tax payable
(34.0
)
(44.7
)
Contract liabilities
(346.3
)
(312.2
)
Provisions
(35.7
)
(36.0
)
Non-cash working capital
$
765.6
$
586.1
Trailing six-month revenues annualized
$
2,529.5
$
3,087.0
Working capital %
30.3
%
19.0
%
The following table reconciles net debt to the most directly comparable IFRS measures:
As at
December 29
2024
March 31
2024
Cash and cash equivalents
$
263.2
$
170.2
Bank indebtedness
(4.3
)
(4.1
)
Current portion of lease liabilities
(30.7
)
(27.6
)
Current portion of long-term debt
(0.2
)
(0.2
)
Long-term lease liabilities
(96.4
)
(83.8
)
Long-term debt
(1,611.0
)
(1,171.8
)
Net Debt
$
(1,479.4
)
$
(1,117.3
)
Pro Forma Adjusted EBITDA (TTM)
$
397.4
$
485.3
Net Debt to Pro Forma Adjusted EBITDA
3.7x
2.3x
Advertisement 12
Article content
The following table reconciles free cash flow to the most directly comparable IFRS measures:
(in millions of dollars)
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Cash flows provided by (used in) operating activities
$
66.7
$
110.5
$
(13.5
)
$
11.2
Acquisition of property, plant and equipment
(6.9
)
(12.0
)
(22.1
)
(46.5
)
Acquisition of intangible assets
(9.5
)
(5.7
)
(27.0
)
(16.0
)
Free cash flow
$
50.3
$
92.8
$
(62.6
)
$
(51.3
)
Certain non-IFRS financial measures exclude the impact on stock-based compensation expense of the revaluation of deferred share units and restricted share units resulting specifically from the change in market price of the Company’s common shares between periods. Management believes the adjustment provides further insight into the Company’s performance.
The following table reconciles total stock-based compensation expense to its components:
(in millions of dollars)
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Total stock-based compensation expense
$
5.1
$
2.7
$
3.7
$
(4.3
)
$
4.7
$
3.5
$
10.0
$
19.3
Less: Mark to market portion of stock-based compensation
1.4
(1.9
)
(1.3
)
(8.5
)
(0.6
)
(2.0
)
4.4
15.1
Base stock-based compensation expense
$
3.7
$
4.6
$
5.0
$
4.2
$
5.3
$
5.5
$
5.6
$
4.2
INVESTMENTS, LIQUIDITY, CASH FLOW AND FINANCIAL RESOURCES
(In millions of dollars, except ratios)
As at
December 29
2024
March 31
2024
Cash and cash equivalents
$
263.2
$
170.2
Debt-to-equity ratio1
1.08:1
0.79:1
1 Debt is calculated as bank indebtedness, long-term debt and lease liabilities. Equity is calculated as total equity less accumulated other comprehensive income.
Three Months
Ended
December 29,
2024
Three Months
Ended
December 31,
2023
Nine Months
Ended
December 29,
2024
Nine Months
Ended
December 31,
2023
Cash, beginning of period
$
246.9
$
187.4
$
170.2
$
159.9
Total cash provided by (used in):
Operating activities
66.7
110.5
(13.5
)
11.2
Investing activities
(30.3
)
(269.3
)
(243.9
)
(315.5
)
Financing activities
(21.6
)
232.8
344.6
406.1
Net foreign exchange difference
1.5
(0.5
)
5.8
(0.8
)
Cash, end of period
$
263.2
$
260.9
$
263.2
$
260.9
ATS CORPORATION
Interim Condensed Consolidated Statements of Financial Position
(in thousands of Canadian dollars – unaudited)
As at
December 29
2024
March 31
2024
ASSETS
Current assets
Cash and cash equivalents
$
263,152
$
170,177
Accounts receivable
709,127
471,345
Income tax receivable
17,668
13,428
Contract assets
619,510
704,703
Inventories
366,207
295,880
Deposits, prepaids and other assets
98,935
98,161
2,074,599
1,753,694
Non-current assets
Property, plant and equipment
320,133
296,977
Right-of-use assets
120,209
105,661
Other assets
3,123
18,416
Goodwill
1,369,149
1,228,600
Intangible assets
754,600
679,547
Deferred income tax assets
24,500
5,904
2,591,714
2,335,105
Total assets
$
4,666,313
$
4,088,799
LIABILITIES AND EQUITY
Current liabilities
Bank indebtedness
$
4,252
$
4,060
Accounts payable and accrued liabilities
629,824
604,488
Income tax payable
33,998
44,732
Contract liabilities
346,271
312,204
Provisions
35,749
35,978
Current portion of lease liabilities
30,688
27,571
Current portion of long-term debt
193
176
1,080,975
1,029,209
Non-current liabilities
Employee benefits
26,262
24,585
Long-term lease liabilities
96,390
83,808
Long-term debt
1,611,039
1,171,796
Deferred income tax liabilities
86,661
81,353
Other long-term liabilities
8,946
14,101
1,829,298
1,375,643
Total liabilities
$
2,910,273
$
2,404,852
EQUITY
Share capital
$
841,559
$
865,897
Contributed surplus
35,982
26,119
Accumulated other comprehensive income
145,608
64,155
Retained earnings
729,346
724,495
Equity attributable to shareholders
1,752,495
1,680,666
Non-controlling interests
3,545
3,281
Total equity
1,756,040
1,683,947
Total liabilities and equity
$
4,666,313
$
4,088,799
Advertisement 13
Article content
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company’s profile on SEDAR+ at www.sedarplus.com, the Company’s profile on the U.S. Securities and Exchange Commission’s website at www.sec.gov, and on the Company’s website at www.atsautomation.com.
ATS CORPORATION
Interim Condensed Consolidated Statements of Income
(in thousands of Canadian dollars, except per share amounts – unaudited)
Three months ended
Nine months ended
December 29
2024
December 31
2023
December 29
2024
December 31
2023
Revenues
$
651,993
$
752,052
$
1,959,044
$
2,241,417
Operating costs and expenses
Cost of revenues
454,061
538,435
1,374,193
1,606,658
Selling, general and administrative
156,365
114,187
430,025
359,811
Restructuring costs
3,360
16,228
20,435
16,228
Stock-based compensation
5,125
4,671
11,548
18,116
Earnings from operations
33,082
78,531
122,843
240,604
Net finance costs
22,440
17,537
65,492
49,945
Income before income taxes
10,642
60,994
57,351
190,659
Income tax expense
4,137
13,812
16,438
45,010
Net income
$
6,505
$
47,182
$
40,913
$
145,649
Attributable to
Shareholders
$
6,414
$
47,048
$
40,809
$
145,276
Non-controlling interests
91
134
104
373
$
6,505
$
47,182
$
40,913
$
145,649
Earnings per share attributable to shareholders
Basic
$
0.07
$
0.48
$
0.42
$
1.49
Diluted
$
0.07
$
0.47
$
0.41
$
1.48
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company’s profile on SEDAR+ at www.sedarplus.com, the Company’s profile on the U.S. Securities and Exchange Commission’s website at www.sec.gov, and on the Company’s website at www.atsautomation.com.
ATS CORPORATION
Interim Condensed Consolidated Statements of Cash Flows
(in thousands of Canadian dollars – unaudited)
Three months ended
Nine months ended
December 29
2024
December 31
2023
December 29
2024
December 31
2023
Operating activities
Net income
$
6,505
$
47,182
$
40,913
$
145,649
Items not involving cash
Depreciation of property, plant and equipment
8,404
7,111
25,152
20,791
Amortization of right-of-use assets
8,563
7,304
24,967
21,656
Amortization of intangible assets
20,943
20,743
64,511
62,393
Deferred income taxes
(9,488
)
(8,693
)
(25,266
)
(9,020
)
Other items not involving cash
(1,605
)
(1,871
)
(2,666
)
(2,433
)
Stock-based compensation
3,281
3,043
9,907
8,146
Change in non-cash operating working capital
30,081
35,689
(151,073
)
(235,977
)
Cash flows provided by (used in) operating activities
$
66,684
$
110,508
$
(13,555
)
$
11,205
Investing activities
Acquisition of property, plant and equipment
$
(6,901
)
$
(12,045
)
$
(22,111
)
$
(46,516
)
Acquisition of intangible assets
(9,506
)
(5,666
)
(27,032
)
(15,971
)
Business acquisitions, net of cash acquired
2,280
(266,117
)
(179,389
)
(275,776
)
Settlement of cross-currency interest rate swap instrument
(16,555
)
—
(16,555
)
—
Proceeds from disposal of property, plant and equipment
350
14,554
1,135
22,809
Cash flows used in investing activities
$
(30,332
)
$
(269,274
)
$
(243,952
)
$
(315,454
)
Financing activities
Bank indebtedness
$
(13,559
)
$
2,495
$
(503
)
$
(378
)
Repayment of long-term debt
(218,569
)
(76,151
)
(505,686
)
(542,095
)
Proceeds from long-term debt
193,836
310,844
908,354
626,828
Settlement of cross-currency interest rate swap instrument
24,262
—
24,262
—
Proceeds from exercise of stock options
52
775
139
1,954
Proceeds from U.S. initial public offering, net of issuance fees
—
—
—
362,072
Purchase of non-controlling interest
—
13
—
(195
)
Repurchase of common shares
—
—
(44,983
)
—
Acquisition of shares held in trust
—
—
(14,690
)
(23,820
)
Principal lease payments
(7,678
)
(5,135
)
(22,244
)
(18,250
)
Cash flows provided by (used in) financing activities
$
(21,656
)
$
232,841
$
344,649
$
406,116
Effect of exchange rate changes on cash and cash equivalents
1,519
(569
)
5,833
(846
)
Increase in cash and cash equivalents
16,215
73,506
92,975
101,021
Cash and cash equivalents, beginning of period
246,937
187,382
170,177
159,867
Cash and cash equivalents, end of period
$
263,152
$
260,888
$
263,152
$
260,888
Supplemental information
Cash income taxes paid
$
21,797
$
7,946
$
51,213
$
33,662
Cash interest paid
$
23,147
$
20,814
$
62,837
$
54,952
Advertisement 14
Article content
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company’s profile on SEDAR+ at www.sedarplus.com, the Company’s profile on the U.S. Securities and Exchange Commission’s website at www.sec.gov, and on the Company’s website at www.atsautomation.com.
Non-IFRS and Other Financial Measures
Throughout this document, management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company.
Advertisement 15
Article content
Following amendments to ATS’ RSU Plan in 2022 to provide the Company with the option for settlement in shares purchased in the open market and the creation of the employee benefit trust to facilitate such settlement, ATS began to account for equity-settled RSUs using the equity method of accounting. However, prior RSU grants which will be cash-settled and deferred share unit (“DSU”) grants which will be cash-settled are accounted for as described in the Company’s annual consolidated financial statements and have volatility period over period based on the fluctuating price of ATS’ common shares. Certain non-IFRS financial measures (adjusted EBITDA, net debt to pro forma adjusted EBITDA, adjusted earnings from operations and adjusted basic earnings per share) exclude the impact on stock-based compensation expense of the revaluation of DSUs and RSUs resulting specifically from the change in market price of the Company’s common shares between periods. Management believes that this adjustment provides insight into the Company’s performance, as share price volatility drives variability in the Company’s stock-based compensation expense.
Operating margin, adjusted earnings from operations, EBITDA, EBITDA margin, adjusted EBITDA, pro forma adjusted EBITDA and adjusted EBITDA margin are used by the Company to evaluate the performance of its operations. Management believes that earnings from operations is an important indicator in measuring the performance of the Company’s operations on a pre-tax basis and without consideration as to how the Company finances its operations. Management believes that organic revenue and organic revenue growth, when considered with IFRS measures, allow the Company to better measure the Company’s performance and evaluate long-term performance trends. Organic revenue growth also facilitates easier comparisons of the Company’s performance with prior and future periods and relative comparisons to its peers. Management believes that EBITDA and adjusted EBITDA are important indicators of the Company’s ability to generate operating cash flows to fund continued investment in its operations. Management believes that adjusted earnings from operations, adjusted earnings from operations margin, adjusted EBITDA, adjusted net income and adjusted basic earnings per share are important measures to increase comparability of performance between periods. The adjustment items used by management to arrive at these metrics are not considered to be indicative of the business’ ongoing operating performance. Management uses the measure “non-cash working capital as a percentage of revenues” to assess overall liquidity. Free cash flow is used by the Company to measure cash flow from operations after investment in property, plant and equipment and intangible assets. Management uses net debt to pro forma adjusted EBITDA as a measurement of leverage of the Company. Order Bookings provide an indication of the Company’s ability to secure new orders for work during a specified period, while Order Backlog provides a measure of the value of Order Bookings that have not been completed at a specified point in time. Both Order Bookings and Order Backlog are indicators of future revenues that the Company expects to generate based on contracts that management believes to be firm. Organic Order Bookings and organic Order Bookings growth allow the Company to better measure the Company’s performance and evaluate long-term performance trends. Organic Order Bookings growth also facilitates easier comparisons of the Company’s performance with prior and future periods and relative comparisons to its peers. Book to bill ratio is used to measure the Company’s ability and timeliness to convert Order Bookings into revenues. Management believes that ATS shareholders and potential investors in ATS use these additional IFRS measures and non-IFRS financial measures in making investment decisions and measuring operational results.
Advertisement 16
Article content
A reconciliation of (i) adjusted EBITDA and EBITDA to net income, (ii) adjusted earnings from operations to net income, (iii) adjusted net income to net income, (iv) adjusted basic earnings per share to basic earnings per share (v) free cash flow to its IFRS measure components and (vi) organic revenue to revenue, in each case for the three- and nine-months ended December 29, 2024 and December 31, 2023 is contained in this document (see “Reconciliation of Non-IFRS Measures to IFRS Measures”). This document also contains a reconciliation of (i) non-cash working capital as a percentage of revenues and (ii) net debt to their IFRS measure components, in each case at both December 29, 2024 and March 31, 2024 (see “Reconciliation of Non-IFRS Measures to IFRS Measures”). A reconciliation of Order Bookings and Order Backlog to total Company revenues for the three- and nine-months ended December 29, 2024 and December 31, 2023 is also contained in this news release (see “Order Backlog Continuity”).
Forward-Looking Statements
This news release contains certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws (“forward-looking statements”). All such statements are made pursuant to the “safe harbour” provisions of Canadian provincial and territorial securities laws and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts regarding possible events, conditions or results of operations that ATS believes, expects or anticipates will or may occur in the future, including, but not limited to: the value creation strategy; the Company’s strategy to expand organically and through acquisition, and the expected benefits to be derived; disciplined acquisitions; various market opportunities for ATS; expanding in emerging markets; expectation on transportation revenues, including the expected decrease in demand for the Company’s solutions in the EV space, and the allocation of resources to other markets; conversion of opportunities into Order Bookings; the announcement of new Order Bookings and the anticipated timeline for delivery; potential impacts on the time to convert opportunities into Order Bookings; the Company’s Order Backlog partially mitigating the impact of variable Order Bookings; the expected benefits where the Company engages with customers on enterprise-type solutions; the potential impact of the Company’s approach to market and timing of customer decisions on Order Bookings, performance period, and timing of revenue recognition; collection of payments from customers, including milestone payments relating to certain large EV programs; expected benefits with respect to the Company’s efforts to grow its product portfolio and after-sale service revenues; the ability of after-sales revenues and reoccurring revenues to provide some balance to customers’ capital expenditure cycles; initiatives in furtherance of the Company’s goal of improving its adjusted earnings from operations margin over the long term; the uncertainty of supply chain dynamics; the anticipated range of revenues for the following quarter; expectation of realization of cost and revenue synergies from integration of acquired businesses; non-cash working capital levels as a percentage of revenues in the short-term and the long-term; planned reorganization activities, including the reorganization activity implemented to reflect the expected decrease in demand for the Company’s solutions in the EV space, and its ability to improve the cost structure of the Company, and the expected timing and cost of the reorganization activities; expectation in relation to meeting liquidity and funding requirements for investments; potential to use debt or equity financing to support strategic opportunities and growth strategy; underlying trends driving customer demand; potential impacts of variability in bookings caused by the strategic nature and size of EV programs; revenue growth in other markets and due to acquisitions to offset any reduced volumes from the EV program in fiscal 2025; expected capital expenditures for fiscal 2025; the uncertainty and potential impact on the Company’s business and operations due to the current macroeconomic environment including the impacts of any epidemic or pandemic outbreak or resurgence, inflation, uncertainty caused by the supply chain dynamics, interest rate changes, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry generally, international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and regional conflicts; the Company’s potential consideration of any private dispute resolution process or litigation in connection with the existing disagreement with an EV customer; and the Company’s belief with respect to the outcome or impact of any lawsuits, claims, counterclaims and contingencies.
Advertisement 17
Article content
Advertisement 18
Article content
Forward-looking statements are necessarily based on a number of estimates, factors, and assumptions regarding, among others, management’s current plans, estimates, projections, beliefs and opinions, the future performance and results of the Company’s business and operations; the ability of ATS to execute on its business objectives; the effectiveness of ABM in accomplishing its goals; the ability to successfully implement margin expansion initiative; initiatives in furtherance of the Company’s goal of improving its adjusted earnings from operations margin over the long term; the anticipated growth in the life sciences, food & beverage, consumer products, and energy markets; the ability to seek out, enter into and successfully integrate acquisitions; ongoing cost inflationary pressures and the Company’s ability to respond to such inflationary pressures; the effects of foreign currency exchange rate fluctuations on its operations; the Company’s competitive position in the industry; the Company’s ability to adapt and develop solutions that keep pace with continuing changes in technology and customer needs; the ability to maintain mutually beneficial relationships with the Company’s customers; and general economic and political conditions, and global events, including any epidemic or pandemic outbreak or resurgence, and the international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and any escalation of such trade disputes.
Forward-looking statements included in this news release are only provided to understand management’s current expectations relating to future periods and, as such, are not appropriate for any other purpose. Although ATS believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and ATS cautions you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. ATS does not undertake any obligation to update forward-looking statements contained herein other than as required by law.
Certain forward-looking information included in this news release may also constitute a “financial outlook” within the meaning of applicable securities laws. Financial outlook involves statements about ATS’ prospective financial performance, financial position or cash flows that is based on and subject to the assumptions about future economic conditions and courses of action described above as well as management’s assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity. Such assumptions are based on management’s assessment of the relevant information currently available and any financial outlook included herein is provided for the purpose of helping readers understand management’s current expectations and plans for the future as of the date hereof. The actual results of ATS’ operations may vary from the amounts set forth in any financial outlook and such variances may be material. Readers are cautioned that reliance on any financial outlook may not be appropriate for other purposes or in other circumstances and that the risk factors described above and other factors may cause actual results to differ materially from any financial outlook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250205374000/en/

Contacts
For more information, contact:
David Galison
Head of Investor Relations
ATS Corporation
730 Fountain Street North
Cambridge, ON, N3H 4R7
(519) 653-6500
dgalison@atsautomation.com
For general media inquiries, contact:
Matthew Robinson
Director, Corporate Communications
ATS Corporation
730 Fountain Street North
Cambridge, ON, N3H 4R7
(519) 653-6500
mrobinson@atsautomation.com
#distro
Article content
Share this article in your social network



